Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |